The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: Knowledge from the 50/10 OIR model

Documenta Ophthalmologica

Volumn 120, Issue 1, 2010, Pages 25-39

  Elizabeth Hartnett, M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

50 10 OIR model; Intravitreous neovascularization; NADPH oxidase; Oxygen; Retinopathy of prematurity; Vascular endothelial growth factor

Indexed keywords

APOCYNIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; JANUS KINASE; MESSENGER RNA; PIGMENT EPITHELIUM DERIVED FACTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STAT PROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; APOPTOSIS; ARTERY DIAMETER; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HYPEROXIA; HYPOXIA; NONHUMAN; OXIDATIVE STRESS; OXYGEN THERAPY; OXYGEN TOXICITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA BLOOD FLOW; RETINA BLOOD VESSEL OCCLUSION; RETINA NEOVASCULARIZATION; RETROLENTAL FIBROPLASIA; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION;

ACETOPHENONES; ANIMALS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HUMANS; INFANT, NEWBORN; NADPH OXIDASE; OXIDATIVE STRESS; OXYGEN; RATS; REACTIVE OXYGEN SPECIES; RETINAL NEOVASCULARIZATION; RETINOPATHY OF PREMATURITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 77249149319     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10633-009-9181-x     Document Type: Review

References (95)

1. JS Penn MM Henry BL Tolman 1994 Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat Pediatr Res 36 724 731 10.1203/00006450-199412000-00007 7898981
2. A Patz A Eastham DH Higginbotham T Kleh 1953 Oxygen studies in retrolental fibroplasia Am J Ophthalmol 36 1511 1522 13104558
3. Patz A (1965) The effect of oxygen on immature retinal vessels [Review] [23 refs]. Invest Ophthalmol 4:988-999
4. BA Berkowitz W Zhang 2000 Significant reduction of the panretinal oxygenation response after 28% supplemental oxygen recovery in experimental ROP Invest Ophthalmol Vis Sci 41 1925 1931 10845618
5. McColm JR, Hartnett ME (2005) Retinopathy of prematurity: current understanding based on clinical trials and animal models. In: Hartnett MEE, Trese MT, Capone A Jr, Steidl SM, Keats BK (eds) Pediatric retinal diseases: medical and surgical approaches. Lippincot Williams & Wilkins, Philadelphia
6. Cryotherapy for Retinopathy of Prematurity Cooperative Group 2001 Multicenter trial of cryotherapy for retinopathy of prematurity ophthalmological outcomes at 10 years Arch Ophthalmol 119 1110 1118
7. Early Treatment for Retinopathy of Prematurity Cooperative Group 2003 Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial Arch Ophthalmol 121 1684 1694 10.1001/archopht.121.12.1684 14662586 (Pubitemid 37517433)
8. JT Flynn 1987 Retinopathy of prematurity Ped Clin N Am 34 1487 1516
9. Cryotherapy for Retinopathy of Prematurity Cooperative Group 2002 Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251 g Arch Ophthalmol 120 595 599
10. JT Ernest TK Goldstick 1984 Retinal oxygen tension and oxygen reactivity in retinopathy of prematurity in kittens Invest Ophthalmol Vis Sci 25 1129 1134 6207136
11. Y Saito A Uppal G Byfield S Budd ME Hartnett 2008 Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model Invest Ophthalmol Vis Sci 49 1591 1598 10.1167/iovs.07-1356 18385079
12. TL Terry 1942 Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens: (1) preliminary report Am J Ophthalmol 25 203 204
13. -/- mice Dev Biol 279 205 219 10.1016/j.ydbio.2004.12.017 15708569 (Pubitemid 40222180)
14. SC Shih M Ju N Liu LEH Smith 2003 Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity J Clin Invest 112 50 57 12840058
15. T Alon I Hemo A Itin J Peer J Stone E Keshet 1995 Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity Nat Med 1 1024 1028 10.1038/nm1095-1024 7489357
16. KH Chang T Chan-Ling EL McFarland A Afzal H Pan LC Baxter LC Shaw S Caballero N Sengupta SL Calzi SM Sullivan MB Grant 2007 IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development Proc Natl Acad Sci USA 104 10595 10600 10.1073/pnas.0702072104 17567755 (Pubitemid 47185710)
17. C Lofqvist J Chen KM Connor ACH Smith CM Aderman N Liu JE Pintar T Ludwig A Hellstrom LEH Smith 2007 From the cover: IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth Proc Natl Acad Sci USA 104 10589 10594 10.1073/pnas.0702031104 17567756 (Pubitemid 47185709)
18. KM Connor JP SanGiovanni C Lofqvist CM Aderman J Chen A Higuchi S Hong EA Pravda S Majchrzak D Carper A Hellstrom JX Kang EY Chew N Salem CN Serhan LEH Smith 2007 Increased dietary intake of [omega]-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis Nat Med 13 868 873 10.1038/nm1591 17589522 (Pubitemid 47038185)
19. J Neu A Afzal H Pan E Gallego SL Calzi S Caballero PE Spoerri LC Shaw MB Grant 2006 The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy Invest Ophthalmol Vis Sci 47 3151 3155 10.1167/iovs.05-1473 16799062 (Pubitemid 351639795)
20. JS Penn 1992 Oxygen-induced retinopathy in the rat. Vitamins C and E as potential therapies Invest Ophthalmol Vis Sci 33 1836 1845 1582786
21. JS Penn BL Tolman LE Bullard 1997 Effect of a water-soluble vitamin E analog, Trolox C, on retinal vascular development in an animal model of retinopathy of prematurity Free Radic Biol Med 22 977 984 10.1016/S0891-5849(96) 00479-0 9034236 (Pubitemid 27084134)
22. MR Niesman KA Johnson JS Penn 1997 Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity Neurochem Res 22 597 605 10.1023/A:1022474120512 9131639
23. Y Saito P Geisen A Uppal ME Hartnett 2007 Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity Mol Vis 13 840 853 17615545
24. N Ashton C Cook 1954 Direct observation of the effect of oxygen on developing vessels: preliminary report Br J Ophthalmol 38 433 440 10.1136/bjo.38.7.433 13172418
25. IC Michaelson 1948 The mode of development of the vascular system of the retina. With some observations on its significance for certain retinal diseases Trans Ophthal Soc UK 68 137 180
26. S Cunningham BW Fleck RA Elton N Mclntosh 1995 Transcutaneous oxygen levels in retinopathy of prematurity Lancet 346 1464 1465 10.1016/S0140-6736(95) 92475-2 7490994
27. JR McColm S Cunningham J Wade K Sedowofia B Gellen T Sharma N McIntosh BW Fleck 2004 Hypoxic oxygen fluctuations produce less severe retinopathy than hyperoxic fluctuations in a rat model of retinopathy of prematurity Pediatr Res 55 107 113 10.1203/01.PDR.0000099772.66376.02 14561784 (Pubitemid 38018698)
28. Y Saito T Omoto Y Cho Y Hatsukawa M Fujimura T Takeuchi 1993 The progression of retinopathy of prematurity and fluctuation in blood gas tension Graefes Arch Clin Exp Ophthalmol 231 151 156 10.1007/BF00920938 8462887
29. LC Chow KW Wright A Sola 2003 Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 111 339 345 10.1542/peds.111.2.339 12563061 (Pubitemid 36177154)
30. A Wedrychowicz H Dziatkowiak J Nazim K Sztefko 2005 Insulin-like growth factor-1 and its binding proteins, IGFBP-1 and IGFBP-3, in adolescents with type-1 diabetes mellitus and microalbuminuria Horm Res 63 5 245 299 10.1159/000085941 15920342 (Pubitemid 41022616)
31. W Tin DWA Milligan PM Pennefather E Hey 2001 Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation Arch Dis Child Fetal Neonat Ed 84 106 110 10.1136/fn.84.2.F106
32. XQ Werdich GW McCollum VS Rajaratnam JS Penn 2004 Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy Exp Eye Res 79 623 630 10.1016/j.exer.2004.07.006 15500821 (Pubitemid 39410365)
33. JR McColm S Cunningham R Yerden 1999 A computer controlled system to simulate the small, rapid oxygen fluctuations experienced by preterm infants developing retinopathy of prematurity Scott Med J 44 1 28 29
34. EA Pierce RL Avery ED Foley LP Aiello LEH Smith 1995 Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization Proc Natl Acad Sci USA 92 905 909 10.1073/pnas.92.3.905 7846076
35. JS Penn MM Henry PT Wall BL Tolman 1995 The range of PaO2 variation determines the severity of oxygen induced retinopathy in newborn rats Invest Ophthalmol Vis Sci 36 2063 2070 7657545
36. DL Phelps 1988 Reduced severity of oxygen-induced retinopathy in kittens recovered in 28% oxygen Pediatr Res 24 106 109 10.1203/00006450-198807000-00024 3412844
37. X Gu S Samuel M El shabrawey RB Caldwell M Bartoli DM Marcus SE Brooks 2002 Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity Invest Ophthalmol Vis Sci 43 496 502 11818396
38. The STOP-ROP Multicenter Study Group 2000 Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes Pediatrics 105 295 310 10.1542/peds.105.2.295
39. DK Wallace KA Veness-Meehan WC Miller 2007 Incidence of severe retinopathy of prematurity before and after a modest reduction in target oxygen saturation levels J AAPOS 11 170 174 10.1016/j.jaapos.2006.08.012 17416327 (Pubitemid 46528779)
40. DK Vanderveen TA Mansfield EC Eichenwald 2006 Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity J AAPOS 10 445 448 10.1016/j.jaapos.2006.04.010 17070480 (Pubitemid 44633728)
41. K Liu JD Akula C Falk RM Hansen AB Fulton 2006 The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity Invest Ophthalmol Vis Sci 47 2639 2647 10.1167/iovs.06-0016 16723481 (Pubitemid 351639852)
42. Hartnett ME, Martiniuk DJ, Byfield GE, Geisen P, Zeng G, Bautch VL (2008) Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in rat model of ROP: relevance to plus disease. Invest Ophthalmol Vis Sci 49(7):3107-3114. Epub 2008 Mar 31
43. JR McColm P Geisen ME Hartnett 2004 VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP Mol Vis 10 512 520 15303088
44. XQ Werdich JS Penn 2006 Specific involvement of Src family kinase activation in the pathogenesis of retinal neovascularization Invest Ophthalmol Vis Sci 47 5047 5056 10.1167/iovs.05-1343 17065526 (Pubitemid 46586412)
45. SR Aylward E Bullitt 2002 Initialization, noise, singularities, and scale in height ridge traversal for tubular object centerline extraction IEEE Trans Med Imaging 21 61 75 10.1109/42.993126 11929106 (Pubitemid 34466421)
46. T Chan-Ling B Gock J Stone 1995 The effect of oxygen on vasoformative cell division: evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis Invest Ophthalmol Vis Sci 36 1201 1214 7775098
47. J Stone A Itin T Alon J Peer H Gnessin T Chan-Ling E Keshet 1995 Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia J Neurosci 15 4738 4747 7623107
48. M Saint-Geniez AE Maldonado PA D'Amore 2006 VEGF expression and receptor activation in the choroid during development and in the adult Invest Ophthalmol Vis Sci 47 3135 3142 10.1167/iovs.05-1229 16799060 (Pubitemid 351639793)
49. ASR Maharaj M Saint-Geniez AE Maldonado PA D'Amore 2006 Vascular endothelial growth factor localization in the adult Am J Pathol 168 639 648 10.2353/ajpath.2006.050834 16436677 (Pubitemid 43271161)
50. GS Robinson LP Aiello 1998 Angiogenic factors in diabetic ocular disease: mechanisms of today, therapies for tomorrow Int Ophthalmol Clin 38 89 102 9604739
51. AP Adamis JW Miller MT Bernal DJ D'Amico J Folkman TK Yeo KT Yeo 1994 Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy Am J Ophthalmol 118 445 450 7943121
52. DW Dawson OV Volpert P Gillis SE Crawford H Xu W Benedict NP Bouck 1999 Pigment epithelium-derived factor: a potent inhibitor of angiogenesis Science 285 245 248 10.1126/science.285.5425.245 10398599 (Pubitemid 29329995)
53. EJ Duh HS Yang I Suzuma M Miyagi E Youngman K Mori M Katai L Yan K Suzuma K West J Pearlman JW Crabb LP Aiello PA Campochiaro DJ Zack 2002 Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth Invest Ophthalmol Vis Sci 43 821 829 11867604
54. K Mori P Gehlbach A Ando D McVey L Wei PA Campochiaro 2002 Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor Invest Ophthalmol Vis Sci 43 2428 2434 12091447
55. G Gao Y Li S Gee A Dudley J Fant C Crosson J Ma 2002 Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor. A possible mechanism for the anti-angiogenesis activity of plasminogen kringle 5 J Biol Chem 277 9492 9497 10.1074/jbc. M108004200 11782462 (Pubitemid 34953037)
56. DT Shima M Kuroki U Deutsch YS Ng AP Adamis PA D'Amore 1996 The mouse gene for vascular endothelial growth factor J Biol Chem 271 3877 3883 10.1074/jbc.271.44.27424 8632007 (Pubitemid 26367300)
57. E Tischer R Mitchell T Hartman M Silva D Gospodarowicz JC Fiddes JA Abraham 1991 The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing J Biol Chem 266 11947 11954 1711045
58. S Ishida T Usui K Yamashiro Y Kaji S Amano Y Ogura T Hida Y Oguchi J Ambati JW Miller ES Gragoudas YS Ng PA D'Amore DT Shima AP Adamis 2003 VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization J Exp Med 198 483 489 10.1084/jem.20022027 12900522 (Pubitemid 36976059)
59. T Usui S Ishida K Yamashiro Y Kaji V Poulaki J Moore T Moore S Amano Y Horikawa D Dartt M Golding DT Shima AP Adamis 2004 VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2 Invest Ophthalmol Vis Sci 45 368 374 10.1167/iovs.03-0106 14744874 (Pubitemid 38140491)
60. S Lee SM Jilani GV Nikolova D Carpizo ML Iruela-Arispe 2005 Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors J Cell Biol 169 681 691 10.1083/jcb.200409115 15911882 (Pubitemid 41002860)
61. I Stalmans YS Ng R Rohan M Fruttiger A Bouche A Yuce H Fujisawa B Hermans M Shani S Jansen D Hicklin DJ Anderson TA Gardiner HP Hammes L Moons M Dewerchin D Collen P Carmeliet PA D'Amore 2002 Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms J Clin Invest 109 327 336 11827992
62. P Carmeliet YS Ng D Nuyens G Theilmeier K Brusselmans I Cornelissen E Ehler VV Kakkar I Stalmans V Mattot J-C Perriard M Dewerchin W Flameng A Nagy F Lupu L Moons D Collen PA D'Amore DT Shima 1999 Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 Nat Med 5 495 501 10.1038/8379 10229225 (Pubitemid 29220207)
63. YS Ng R Rohan ME Sunday DE Demello PA D'Amore 2001 Differential expression of VEGF isoforms in mouse during development and in the adult Dev Dyn 220 112 121 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1093>3.0.CO;2-D 11169844 (Pubitemid 32107812)
64. C Ruhrberg H Gerhardt M Golding R Watson S Ioannidou H Fujisawa C Betsholtz DT Shima 2002 Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis Genes Dev 16 2684 2698 10.1101/gad.242002 12381667
65. H Hutchings N Ortega J Plouet 2003 Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation FASEB J 17 1520 1522 12709411
66. E Pierce E Foley EH Lois 1996 Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity Arch Ophthalmol 114 1219 1228 8859081 (Pubitemid 26338853)
67. H Gerhardt M Golding M Fruttiger C Ruhrberg A Lundkvist A Abramsson M Jeltsch C Mitchell K Alitalo D Shima C Betsholtz 2003 VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia J Cell Biol 161 1163 1177 10.1083/jcb.200302047 12810700 (Pubitemid 36870177)
68. P Geisen LJ Peterson D Martiniuk A Uppal Y Saito ME Hartnett 2008 Neutralizing antibody to VEGF reduces intravitreous neovascularization and does not interfere with vascularization of avascular retina in an ROP model Mol Vis 14 345 357 18334951
69. S Hughes T Gardiner L Baxter T Chan-Ling 2007 Changes in pericytes and smooth muscle cells in the kitten model of retinopathy of prematurity: implications for plus disease Invest Ophthalmol Vis Sci 48 1368 1379 10.1167/iovs.06-0850 17325186 (Pubitemid 351261437)
70. D Holland R Saunders L Kagemann E Bluestein A Hutchinson D Corson A Harris 1999 Color Doppler imaging of the central retinal artery in premature infants undergoing examination for retinopathy of prematurity J AAPOS 3 194 198 10.1016/S1091-8531(99)70002-9 10477220
71. A Niwald M Gralek 2006 Evaluation of blood flow in the ophthalmic artery and central retinal artery in children with retinopathy of prematurity Klin Oczna 108 32 35 16883936
72. SE Brooks X Gu S Samuel DM Marcus M Bartoli PL Huang RB Caldwell 2001 Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice Invest Ophthalmol Vis Sci 42 222 228 11133872
73. G Zeng SM Taylor JR McColm NC Kappas JB Kearney LH Williams ME Hartnett VL Bautch 2007 Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation Blood 109 1345 1352 10.1182/blood-2006- 07-037952 17068148 (Pubitemid 46239563)
74. ML Katz WG Robison Jr 1988 Autoxidative damage to the retina: potential role in retinopathy of prematurity Birth Defects 24 237 248 2846086
75. JS Penn 1990 Oxygen-induced retinopathy in the rat: possible contribution of peroxidation reactions Doc Ophthalmol 74 179 186 10.1007/BF02482607 2209375 (Pubitemid 20275851)
76. DL Phelps AL Rosenbaum 1979 Observations of vitamin E in experimental oxygen-induced retinopathy Ophthalmology 86 1741 1748 95420
77. JS Penn BL Tolman LA Lowery 1993 Variable oxygen exposure causes preretinal neovascularisation in the newborn rat Invest Ophthalmol Vis Sci 34 576 585 8449677
78. M Ushio-Fukai 2006 Redox signaling in angiogenesis: role of NADPH oxidase Cardiovasc Res 71 226 235 10.1016/j.cardiores.2006.04.015 16781692 (Pubitemid 43913733)
79. H Jay Forman M Torres 2001 Redox signaling in macrophages Mol Aspects Med 22 189 216 10.1016/S0098-2997(01)00010-3 (Pubitemid 33000522)
80. M Al Shabrawey M Bartoli AB El Remessy DH Platt S Matragoon MA Behzadian RW Caldwell RB Caldwell 2005 Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy Am J Pathol 167 599 607 16049343
81. TNK Raju P Langenberg V Bhutani GE Quinn 1997 Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials J Pediatr 131 844 850 10.1016/S0022-3476(97)70031-3 9427888 (Pubitemid 28027608)
82. AA Kramerov M Saghizadeh H Pan A Kabosova M Montenarh K Ahmed JS Penn CK Chan DR Hinton MB Grant AV Ljubimov 2006 Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina Am J Pathol 168 1722 1736 10.2353/ajpath.2006.050533 16651637
83. MI Dorrell E Aguilar L Scheppke FH Barnett M Friedlander 2007 Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis Proc Natl Acad Sci USA 104 967 972 10.1073/pnas.0607542104 17210921 (Pubitemid 46154720)
84. N Jo C Mailhos M Ju E Cheung J Bradley K Nishijima GS Robinson AP Adamis DT Shima 2006 Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization Am J Pathol 168 2036 2053 10.2353/ajpath.2006.050588 16723717 (Pubitemid 43825322)
85. JE Sears J Pietz C Sonnie D Dolcini G Hoppe 2009 A change in oxygen supplementation can decrease the incidence of retinopathy of prematurity Ophthalmology 116 513 518 10.1016/j.ophtha.2008.09.051 19157560
86. Byfield GE, Budd S, Hartnett ME (2009) Supplemental oxygen can cause intravitreous neovascularization through JAK/STAT pathways in a model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. Epub (Mar 5), PMID: 19264880
87. M Ushio-Fukai RW Alexander 2004 Reactive oxygen species as mediators of angiogenesis signaling. Role of NAD(P)H oxidase Mol Cell Biochem V264 85 97 10.1023/B:MCBI.0000044378.09409.b5 (Pubitemid 39366107)
88. M Ushio-Fukai 2007 VEGF signaling through NADPH oxidase-derived ROS Antioxid Redox Signal 9 731 739 10.1089/ars.2007.1556 17511588 (Pubitemid 46799105)
89. T Liu S Castro AR Brasier M Jamaluddin RP Garofalo A Casola 2004 Reactive oxygen species mediate virus-induced STAT activation: role of tyrosine phosphatases J Biol Chem 279 2461 2469 10.1074/jbc.M307251200 14578356 (Pubitemid 38114229)
90. YJ Lee JS Heo HN Suh MY Lee HJ Han 2007 Interleukin-6 stimulates {alpha}-MG uptake in renal proximal tubule cells: involvement of STAT3, PI3K/Akt, MAPKs, and NF-{kappa}B Am J Physiol Renal Physiol 293 F1036 F1046 10.1152/ajprenal.00034.2007 17581928 (Pubitemid 47583935)
91. AK Banes S Shaw JA Jenkins H Redd F Amiri DM Pollock MB Marrero 2004 Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli Am J Physiol Renal Physiol 286 F653 F659 10.1152/ajprenal.00163.2003 14678947
92. GS Robinson EA Pierce SL Rook E Foley R Webb LEH Smith 1996 Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy Proc Natl Acad Sci USA 93 4851 4856 10.1073/pnas.93.10.4851 8643492 (Pubitemid 26162840)
93. JD Akula RM Hansen ME Martinez-Perez AB Fulton 2007 Rod photoreceptor function predicts blood vessel abnormality in retinopathy of prematurity Invest Ophthalmol Vis Sci 48 4351 4359 10.1167/iovs.07-0881 17724227 (Pubitemid 351260885)
94. BA Berkowitz R Roberts JS Penn M Gradianu 2007 High-resolution manganese-enhanced MRI of experimental retinopathy of prematurity Invest Ophthalmol Vis Sci 48 4733 4740 10.1167/iovs.06-1516 17898298 (Pubitemid 351260992)
95. SJ Cringle PK Yu EN Su DY Yu 2006 Oxygen distribution and consumption in the developing rat retina Invest Ophthalmol Vis Sci 47 4072 4076 10.1167/iovs.05-1638 16936126 (Pubitemid 46044327)